You have 9 free searches left this month | for more free features.

engraftment

Showing 1 - 25 of 1,829

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Engraftment Syndrome Trial (Budesonide)

Not yet recruiting
  • Engraftment Syndrome
  • (no location specified)
Aug 19, 2022

Leukemia, Stem Cell Transplant, Cord Blood Trial in Guangzhou (applying of FLU+CY post-HSCT)

Recruiting
  • Leukemia
  • +2 more
  • applying of FLU+CY post-HSCT
  • Guangzhou, Guangdong, China
    Nanfang Hospital
Nov 23, 2023

Stem Cells Mobilization, colLection and Engraftment in Newly

Recruiting
  • Multiple Myeloma
  • +3 more
  • Rome, Italy
    Fondazione Policlinico Universitario A.Gemelli IRCCS
Apr 28, 2023

Hematological Disease, Allogeneic Hematopoietic Stem Cell Transplantation Trial in Tianjin (Hetrombopag, )

Recruiting
  • Hematological Disease
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital, Chinese Acade
Feb 6, 2023

Bone Marrow Transplant Complications, Fatigue, Vital Signs Trial in Ankara (Reiki)

Recruiting
  • Bone Marrow Transplant Complications
  • +3 more
  • Reiki
  • Ankara, None Selected, Turkey
    Nursemin Ünal
Jan 19, 2023

Immune Tolerance Trial in Palo Alto (Combined Deceased Donor Kidney and Hematopoietic Cell Transplants)

Enrolling by invitation
  • Immune Tolerance
  • Combined Deceased Donor Kidney and Hematopoietic Cell Transplants
  • Palo Alto, California
    Stanford University
May 6, 2022

B-cell NHL, CLL Trial (CARCIK-CD19)

Not yet recruiting
  • B-cell NHL
  • CLL
  • CARCIK-CD19
  • (no location specified)
May 19, 2023

PLT After Allogenic Hematopoietic Stem Cell Transplantation Trial (Avatrombopag, rhTPO)

Not yet recruiting
  • PLT After Allogenic Hematopoietic Stem Cell Transplantation
  • (no location specified)
Nov 21, 2021

Type 1 Diabetes Trial in United States (VC-01 Combination Product)

Active, not recruiting
  • Type 1 Diabetes
  • VC-01 Combination Product
  • Escondido, California
  • +3 more
Feb 18, 2022

Stem Cell Transplant Complications Trial in Suzhou (Eltrombopag 25 MG Oral Tablet, Thrombopoietin)

Not yet recruiting
  • Stem Cell Transplant Complications
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jul 17, 2022

Pre-engraftment Cytomegalovirus DNAemia

Completed
  • CMV DNAemia Pre-engraftment
    • Valencia, Spain
      Clinical University Hospital of Valencia
    Nov 18, 2020

    Kidney Transplant, Type 1 Diabetes Trial in Boston (Alpha 1-Antitrypsin, Islet Transplantation, Thymoglobulin)

    Active, not recruiting
    • Kidney Transplant
    • Type 1 Diabetes
    • Alpha 1-Antitrypsin
    • +4 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Nov 15, 2021

    Chronic Myeloid Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Atlanta (G-CSF mobilized CD34+ selected

    No longer available
    • Chronic Myeloid Leukemia
    • +2 more
    • G-CSF mobilized CD34+ selected cells for transplantation
    • Atlanta, Georgia
      Emory University/Winship Cancer Institute
    Feb 28, 2022

    Junctional Epidermolysis Bullosa Non-Herlitz Type Trial in Paris, Modena (Transplantation)

    Recruiting
    • Junctional Epidermolysis Bullosa Non-Herlitz Type
    • Paris, France
    • +1 more
    Aug 8, 2022

    Hematologic Malignancies Trial in Minneapolis (Romiplostim)

    Completed
    • Hematologic Malignancies
    • Minneapolis, Minnesota
      University of Minnesota Masonic Cancer Center
    Jun 5, 2021

    Lymphoma Trial in Madison (drug, radiation, biological, procedure)

    Completed
    • Lymphoma
    • Fludarabine Phosphate
    • +9 more
    • Madison, Wisconsin
      University of Wisconsin Carbone Cancer Center
    Dec 7, 2021

    Fanconi Anemia Trial in Stanford (drug, device, biological)

    Recruiting
    • Fanconi Anemia
    • Stanford, California
      Stanford University
    Feb 2, 2022

    Non-Hodgkin's Lymphoma, B-Cell ALL, B-Cell CLL Trial in Houston (CD19.CAR-CD28Z T Cells - dose escalation 2, CD19.CAR-CD28Z T

    Recruiting
    • Non-Hodgkin's Lymphoma
    • +2 more
    • CD19.CAR-CD28Z T Cells - dose escalation 2
    • CD19.CAR-CD28Z T Cells - dose escalation 1
    • Houston, Texas
    • +1 more
    Feb 10, 2022

    HIV Trial in United States (SB-728mR-HSPC Infusion 3 days following busulfan conditioning)

    Active, not recruiting
    • HIV
    • SB-728mR-HSPC Infusion 3 days following busulfan conditioning
    • Duarte, California
    • +4 more
    Mar 7, 2022

    Poor Graft Function, Stem Cell Transplantation, GVHD Trial in Beijing (infusion of G-CSF mobilized peripheral harvest)

    Completed
    • Poor Graft Function
    • +2 more
    • infusion of G-CSF mobilized peripheral harvest
    • Beijing, Beijing, China
      Peking University Institute of Hematology
    Sep 23, 2020

    Double Cord Blood Transplant, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (TXA127 300 mcg/kg/day,

    Terminated
    • Double Cord Blood Transplant
    • +8 more
    • TXA127 300 mcg/kg/day
    • TXA127 1000 mcg/kg/day
    • Houston, Texas
      MD Anderson Cancer Center
    Dec 7, 2020

    SCID Trial in United States (Humanized anti-CD117 Monoclonal Antibody (JSP191))

    Recruiting
    • SCID
    • Humanized anti-CD117 Monoclonal Antibody (JSP191)
    • Los Angeles, California
    • +7 more
    Nov 16, 2021

    Acne Vulgaris Trial in San Diego, Arlington, Austin (NB01, Vehicle Control)

    Completed
    • Acne Vulgaris
    • NB01
    • Vehicle Control
    • San Diego, California
    • +2 more
    Jul 9, 2020

    Acne Vulgaris Trial in Los Angeles (NB01)

    Completed
    • Acne Vulgaris
    • NB01
    • Los Angeles, California
      Dermatology Research Associates
    Jul 10, 2020

    Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia Trial in United States (drug, radiation,

    Recruiting
    • Acute Erythroid Leukemia
    • +10 more
    • San Francisco, California
    • +5 more
    Nov 1, 2022